Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_assertion description "[We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_assertion evidence source_evidence_literature NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_assertion SIO_000772 16114055 NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_assertion wasDerivedFrom befree-20150227 NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_assertion wasGeneratedBy ECO_0000203 NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP672999.RAWlXVQhJ-Boyru4GCS6DMEo8vq3OWOV0e2wcEfreCRb4130_provenance.